###begin article-title 0
Male-Specific Association between a gamma-Secretase Polymorphism and Premature Coronary Atherosclerosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: KMJvL TD GJMM. Performed the experiments: KMJvL TD MvZ JEvS. Analyzed the data: KMJvL TD MvZ JEvS MDT GJMM. Contributed reagents/materials/analysis tools: CW MDT. Wrote the paper: KMJvL TD MvZ JEvS CW MDT GJMM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 244 247 <span type="species:ncbi:10116">rat</span>
Atherosclerosis is a common multifactorial disease resulting from an interaction between susceptibility genes and environmental factors. The causative genes that contribute to atherosclerosis are elusive. Based on recent findings with a Wistar rat model, we speculated that the gamma-secretase pathway may be associated with atherosclerosis.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 356 364 <span type="species:ncbi:9606">patients</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
We have tested for association of premature coronary atherosclerosis with a non-synonymous single-nucleotide polymorphism (SNP) in the gamma-secretase component APH1B (Phe217Leu; rs1047552), a SNP previously linked to Alzheimer's disease. Analysis of a Dutch Caucasian cohort (780 cases; 1414 controls) showed a higher prevalence of the risk allele in the patients (odds ratio (OR) = 1.35), albeit not statistically different from the control population. Intriguingly, after gender stratification, the difference was significant in males (OR = 1.63; p = 0.033), but not in females (OR = 0.50; p = 0.20). Since Phe217Leu-mutated APH1B showed reduced gamma-secretase activity in mouse embryonic fibroblasts, the genetic variation is likely functional.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
We conclude that, in a male-specific manner, disturbed gamma-secretase signalling may play a role in the susceptibility for premature coronary atherosclerosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Horejsi1">[1]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Salazar1">[2]</xref>
###xml 344 347 344 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Morita1">[3]</xref>
###xml 593 596 593 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Cools1">[4]</xref>
###xml 598 601 598 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Ellenbroek1">[5]</xref>
###xml 721 724 721 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Riksen1">[6]</xref>
###xml 726 729 726 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Smits1">[7]</xref>
###xml 874 877 874 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Hadi1">[8]</xref>
###xml 1050 1053 1046 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Coolen1">[9]</xref>
###xml 1382 1386 1368 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Kopan1">[10]</xref>
###xml 1388 1392 1374 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Koo1">[11]</xref>
###xml 446 457 <span type="species:ncbi:10116">Wistar rats</span>
###xml 588 592 <span type="species:ncbi:10116">rats</span>
###xml 716 720 <span type="species:ncbi:10116">rats</span>
###xml 1045 1049 <span type="species:ncbi:10116">rats</span>
Atherosclerosis is the basis of coronary artery disease and thought to be a multifactorial disease caused by susceptibility genes that act in concert with environmental factors. A number of susceptibility genes have been identified (e.g. apolipoprotein E (APOE) [1], low density lipoprotein receptor [2] and methylenetetrahydrofolate reductase [3]), but the signalling pathways responsible for vascular cell pathology are elusive. Interestingly, Wistar rats that display a high susceptibility for the dopamine receptor agonist apomorphine, the so-called apomorphine-susceptible (APO-SUS) rats [4], [5], show an impaired vasorelaxation to adrenergic stimuli when compared with their phenotypic counterparts APO-UNSUS rats [6], [7]. Impaired vasorelaxation is associated with an increased risk for the development of hypertension and vascular diseases such as atherosclerosis [8]. We recently identified a gene-dosage imbalance of the gamma-secretase component Aph1b as the molecular-genetic basis of the difference between the APO-SUS and -UNSUS rats [9]. The gamma-secretase enzyme complex cleaves many type I transmembrane proteins, including the amyloid-beta (Abeta) precursor protein APP (known to be involved in neuronal amyloid plaque formation in Alzheimer's disease [AD]), NOTCH1-4, neuregulin, low-density lipoprotein receptor related protein (LRP1, 2 and 8) and N-cadherin [10], [11].
###end p 9
###begin p 10
###xml 426 430 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 435 439 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP1</italic>
###xml 439 442 435 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Horejsi1">[1]</xref>
###xml 444 448 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Rubinsztein1">[12]</xref>
###xml 449 453 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Kang1">[14]</xref>
###xml 562 567 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 622 626 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Poli1">[15]</xref>
###xml 556 561 <span type="species:ncbi:9606">human</span>
In view of the above findings, we hypothesize that the gamma-secretase pathway may be linked to atherosclerosis. Increasing evidence suggests a link between altered vascular homeostasis, as seen in atherosclerosis, and the neurodegenerative disease AD. Apart from a partially overlapping epidemiology and an altered cholesterol homeostasis, atherosclerosis and AD have also been found to share genetic risk factors, including APOE and LRP1[1], [12]-[14]. Since the rare non-synonymous single-nucleotide polymorphism (SNP) Phe217Leu (rs1047552; T>G) in the human APH1B gene has recently been found to be associated with AD [15], we have now tested whether this SNP is also associated with premature coronary atherosclerosis.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
Male-specific association of APH1B Phe217Leu with premature coronary atherosclerosis
###end title 12
###begin p 13
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1b</italic>
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Coolen1">[9]</xref>
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Riksen1">[6]</xref>
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Smits1">[7]</xref>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 591 592 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 601 603 599 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">df</italic>
###xml 748 749 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 758 760 754 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">df</italic>
###xml 858 859 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 868 870 862 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">df</italic>
###xml 914 921 908 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003662-t001">Table 1</xref>
###xml 102 105 <span type="species:ncbi:10116">rat</span>
###xml 335 341 <span type="species:ncbi:9606">humans</span>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
Since a gene-dosage imbalance of the Aph1b gene was the molecular-genetic basis of the APO-SUS/-UNSUS rat model [9] and the model was characterized by a disturbed endothelium-dependent vascular reactivity [6], [7], we tested the hypothesis that a genetic variation in the APH1B gene may contribute to atherosclerosis susceptibility in humans. In a Dutch case-control cohort consisting of 780 patients with premature coronary atherosclerosis and 1414 controls, we found a higher prevalence of the APH1B Phe217Leu risk allele (G-allele) in the patients, albeit not statistically different (chi2 = 2.09, df = 1, p = 0.15; OR = 1.35; CI = 0.90-2.01). Intriguingly, after gender stratification, the difference was significant in the male population (chi2 = 4.52, df = 1, p = 0.033; OR = 1.63; CI = 1.04-2.58), whereas females were not significantly different (chi2 = 1.62, df = 1, p = 0.20; OR = 0.50; CI = 0.17-1.48) (Table 1). Power analysis showed that for the detection in the female subpopulation of a risk effect similar to that observed in the male subpopulation, the power was insufficient (92% power for the total population; 81% power for the male subpopulation and 38% power for the female subpopulation, assuming a relative risk of 1.63, a disease allele frequency of 3.3% and a disease prevalence of 5%). All genotype distributions tested (cases and controls) fulfilled the Hardy-Weinberg criteria (data not shown).
###end p 13
###begin title 14
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
Genotype and allele frequencies for the APH1B Phe217Leu variation in a Dutch case-control study on premature coronary atherosclerosis.
###end title 14
###begin p 15
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Standard Chi-square tests were applied to evaluate the association with premature coronary atherosclerosis. OR = odds ratio; *p<0.05.
###end p 15
###begin title 16
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
Association of APH1B Leu217 with fibrinogen levels in premature coronary atherosclerosis
###end title 16
###begin p 17
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 415 422 415 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003662-t002">Table 2</xref>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 493 500 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003662-t002">Table 2</xref>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 835 842 831 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003662-t002">Table 2</xref>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
###xml 638 646 <span type="species:ncbi:9606">Patients</span>
###xml 751 759 <span type="species:ncbi:9606">patients</span>
###xml 863 870 <span type="species:ncbi:9606">patient</span>
We then compared the association of the APH1B Leu217 allele with clinical parameters in the atherosclerosis patients, including the presence of risk factors (e.g. smoking behavior and occurrence of hypertension and diabetes mellitus), and the blood levels of lipid compounds (e.g. cholesterol, triglycerides, and low- and high-density lipoprotein cholesterol) (for a detailed overview of the parameters tested, see Table 2). These parameters were not related to the APH1B Phe217Leu variation (Table 2), except for a significant association (p = 0.028) with the fibrinogen levels in patients containing or lacking the APH1B Leu217 allele. Patients without the Leu217 allele displayed fibrinogen levels of 322.8+/-80.55 gr/l (n = 327, plus SD), whereas patients with the Leu217 allele had levels of 375.0+/-82.08 gr/l (n = 12, plus SD) (Table 2); due to low female patient numbers, gender stratification for fibrinogen levels was not possible. After Bonferroni adjustment for multiple comparisons, however, no statistically significant association of the fibrinogen levels with the Leu217 allele was detected (Bonferroni's adjustment requires a significance level of p</=0.00156).
###end p 17
###begin title 18
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Clinical and biochemical characteristics of the premature coronary atherosclerosis patients with and without the APH1B 217Leu allele.
###end title 18
###begin p 19
###xml 194 195 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Values are given as mean levels+/-SD or as percentages. N, number of individuals tested; BMI, body mass index; LDL, low density lipoprotein; HDL, high density lipoprotein; Apo, apolipoprotein. *p<0.05.
###end p 19
###begin title 20
Evolutionary conservation of amino acid residue Phe217 within the APH1 family
###end title 20
###begin p 21
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1</italic>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003662-g001">Figure 1</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Yue1">[16]</xref>
###xml 318 321 <span type="species:ncbi:9606">man</span>
The degree of conservation of an amino acid within a protein family is usually indicative of its importance for protein functioning. A multiple sequence alignment of members of the APH1 family (Figure 1) showed that the Phe217 residue is conserved from plant, invertebrates, lower vertebrates, rodents and primates to man. The various APH1 proteins all contain at residue 217 either a phenylalanine (F) or the conservative change to tyrosine (Y). The Support Vector Machine (SVM) score () [16] of -1.12 for Phe217Leu indicates a likely impact of this substitution on APH1B protein function.
###end p 21
###begin title 22
Alignment of vertebrate and invertebrate amino acid sequences of the region within APH1 surrounding residue 217.
###end title 22
###begin p 23
###xml 141 153 141 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 159 174 159 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 180 197 180 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 203 215 203 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 221 239 221 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 245 256 245 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 262 285 262 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 291 313 291 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 319 339 319 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arabidopsis thaliana</italic>
###xml 141 153 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 159 174 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 180 197 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 203 215 <span type="species:ncbi:10090">Mus musculus</span>
###xml 221 239 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 245 256 <span type="species:ncbi:7955">Danio rerio</span>
###xml 262 285 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 291 313 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 319 339 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
A black background indicates identical amino acid residues; a grey background indicates a conservative amino acid change. Abbreviations: Hs, Homo sapiens; Pt, Pan troglodytes; Rn, Rattus norvegicus; Mm, Mus musculus; Xt, Xenopus tropicalis; Dr, Danio rerio; Dm, Drosophila melanogaster; Ce, Caenorhabditis elegans; At, Arabidopsis thaliana. Sequences were aligned using Vector NTI (9.0) with default parameters.
###end p 23
###begin title 24
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
Functional analysis of the APH1B Phe217Leu polymorphism
###end title 24
###begin p 25
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 142 152 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1abc<sup>&#8722;/&#8722;</sup></italic>
###xml 489 493 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Schulz2">[17]</xref>
###xml 667 675 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003662-g002">Figure 2</xref>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
We wondered whether the presence of a leucine instead of the conserved residue Phe217 of the APH1B protein would be of functional importance. Aph1abc-/- mouse embryonic fibroblasts were stably transfected with human APH1B Phe217 or Leu217. gamma-Secretase activity was measured by quantifying the levels of different gamma-secretase substrates in cell culture extracts. We observed a 1.6-fold reduction (p<0.05, n = 8) of gamma-secretase activity towards one of its substrates, syndecan-3 [17], indicating a subtle influence on gamma-secretase cleavage activity. The cleavages of two other substrates, N-cadherin and APP, were slightly but not significantly changed (Figure 2). Thus, in a substrate-dependent manner the Phe217Leu substitution affected gamma-secretase cleavage activity.
###end p 25
###begin title 26
###xml 131 134 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 124 134 120 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1abc<sup>&#8722;/&#8722;</sup></italic>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
gamma-Secretase cleavage activity of human wild-type APH1B (Phe217) and human mutant APH1B (Leu217) stably transfected into Aph1abc-/- mouse embryonic fibroblast cells.
###end title 26
###begin p 27
###xml 666 667 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
The levels of the C-terminal fragments (CTFs) of N-cadherin, APP and syndecan 3 were analysed in cells stably transfected with human APH1B Phe217 (WT) or human APH1B Leu217 (MUT). In the MUT cells, the CTF levels of N-cadherin and APP were slightly increased (1.1-fold and 1.2-fold, respectively), but the difference failed to reach significance. The levels of syndecan-3-CTF were significantly increased (1.6-fold; p = 0.044), indicating a reduced gamma-secretase cleavage activity. Bars represent quantifications of CTF signals normalized to full-length protein levels in eight stably transfected cell lines with the average level in WT cell lines set to 100%. *: p<0.05.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 370 375 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1b</italic>
###xml 427 430 423 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Coolen1">[9]</xref>
###xml 539 542 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Riksen1">[6]</xref>
###xml 544 547 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Smits1">[7]</xref>
###xml 666 671 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1b</italic>
###xml 872 875 864 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Coolen1">[9]</xref>
###xml 924 929 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 1195 1200 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 1273 1277 1261 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Poli1">[15]</xref>
###xml 1449 1453 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Casserly1">[18]</xref>
###xml 1571 1575 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Roher1">[19]</xref>
###xml 1581 1586 1569 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 417 420 <span type="species:ncbi:10116">rat</span>
###xml 709 713 <span type="species:ncbi:10116">rats</span>
###xml 752 756 <span type="species:ncbi:10116">rats</span>
###xml 979 982 <span type="species:ncbi:10116">rat</span>
###xml 1009 1014 <span type="species:ncbi:9606">human</span>
In this study we show that the non-synonymous Phe217Leu polymorphism in the human APH1B gene is a male-specific risk factor for premature coronary atherosclerosis. The reduced gamma-secretase cleavage activity of Leu217 APH1B, albeit in a substrate-specific manner, suggests a functional relevance of this polymorphism. Functional consequences of reduced gene dosage of Aph1b were also observed in the APO-SUS/-UNSUS rat model [9], an animal model with complex features, including an impaired vasorelaxation response to adrenergic stimuli [6], [7], which increases the risk for the development of hypertension and vascular diseases. The gene-dosage imbalance of the Aph1b gene (three gene copies in APO-UNSUS rats and one or two gene copies in APO-SUS rats) segregated with differences in gamma-secretase cleavage activity and a number of other phenotypic characteristics [9]. We therefore speculate that a subtle effect on APH1B expression or function (copy number variation in rat or Phe217Leu variation in human, respectively) may affect gamma-secretase activity and signalling downstream of gamma-secretase cleavage and, consequently, give rise to vascular complications. Interestingly, the APH1B Phe217Leu polymorphism was recently found to be also associated with AD [15]. AD pathogenesis is frequently characterized by a peripheral vascular disturbance and is often linked to other cholesterol/lipoprotein diseases, including atherosclerosis [18]. In addition, cerebral atherosclerosis has been found to be a strong contributory factor to sporadic AD pathogenesis [19]. The APH1B Phe217Leu variation may thus play a dual role by affecting atherosclerosis as well as AD pathogenesis, suggesting that the two diseases have converged and that the gamma-secretase signalling pathway is a susceptibility pathway for vascular complications.
###end p 29
###begin p 30
###xml 126 129 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP</italic>
###xml 272 276 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDLR</italic>
###xml 339 343 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Luoma1">[20]</xref>
###xml 345 349 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Hiltunen1">[21]</xref>
###xml 424 428 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Schulz1">[13]</xref>
###xml 561 565 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Nelson1">[22]</xref>
###xml 598 602 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Rebeck1">[23]</xref>
###xml 885 890 870 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 925 931 910 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH3</italic>
###xml 1128 1132 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Wang1">[24]</xref>
###xml 1255 1259 1240 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Rajavashisth1">[25]</xref>
###xml 1339 1343 1324 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Vendrov1">[26]</xref>
###xml 1424 1428 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Gassmann1">[27]</xref>
###xml 1429 1433 1414 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Meyer1">[29]</xref>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
In line with the above supposition, a number of the gamma-secretase substrates have been implicated in vascular pathogenesis. LRP, which belongs to a gene family involved in mediating cellular uptake of cholesterol-rich lipoproteins (the low-density lipoprotein receptor (LDLR) gene family), is highly expressed in atherosclerotic lesions [20], [21] and has been shown to represent a susceptibility gene for atherosclerosis [13]. The AD-associated gamma-secretase substrate APP may be involved in vascular pathogenesis as well, since it metabolises cholesterol [22], physically interacts with LRP1 [23], and gives rise to the amyloid plaque constituents Abeta-40 and -42. Besides these well-studied substrates, the gamma-secretase substrates NOTCH3, colony-stimulating factor 1 (CSF1), CD44, neuregulin and ERBB4 may also be involved in the vascular complications in patients with the APH1B Phe217Leu variation. Mutations in NOTCH3 may cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephelopathy (CADASIL), a syndrome characterized by systemic vascular smooth muscle cell (VSMC) degeneration [24]. CSF1 can contribute to atherosclerosis development via fatty streak formation and progression to complex fibrous lesions [25], and CD44 may enhance atherosclerosis pathogenesis via reactive oxygen species [26], whereas neuregulin and ERBB4 are necessary for vascular growth and development [27]-[29].
###end p 30
###begin p 31
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE2</italic>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE4</italic>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Lahoz1">[30]</xref>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 756 764 <span type="species:ncbi:9606">patients</span>
###xml 876 884 <span type="species:ncbi:9606">patients</span>
Our results show that, remarkably, only male individuals with atherosclerosis seem to be associated with the APH1B Phe217Leu variation. This might indicate a role for hormones or the involvement of a Y-chromosome-linked modulation. Such a gender-specific association has been observed for other SNPs as well, like a male-specific association of the APOE2 and APOE4 alleles with cardiovascular disease [30]. Thus, susceptibility to many common diseases may well be the result of complex interactions involving gender, genes and environmental factors. Following Bonferroni correction for multiple testing, no significant associations between the APH1B polymorphism and plasma lipoprotein parameters or other risk factors were observed in the atherosclerosis patients. More detailed studies will be necessary to establish the biochemical mechanisms underlying atherosclerosis in patients carrying the Phe217Leu polymorphism.
###end p 31
###begin p 32
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Rissanen1">[31]</xref>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-ODonnell1">[32]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-McPherson1">[35]</xref>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 825 830 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 1099 1100 1099 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1232 1237 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 345 353 <span type="species:ncbi:9606">patients</span>
In the present study, association was only tested for premature coronary atherosclerosis, a disease with a substantial heritability [31]. To investigate whether the Phe217Leu SNP constitutes a susceptibility factor for other vascular complications, it would be of interest to also test for association in elderly atherosclerotic patients and in patients with other vascular defects (e.g. myocardial infarction). No significant association of the APH1B chromosomal region with coronary artery disease, myocardial infarction or other related diseases has been found in recent genome-wide association studies (GWAS) [32]-[35]. Thus, apart from the functional Phe217Leu polymorphism, the contribution of any additional genetic variant in the APH1B gene to the phenotype is expected to be small. Unfortunately, no results for the APH1B Phe217Leu polymorphism are available from the GWAS since this polymorphism was not represented on the arrays used in these studies. In addition, based on the data from the International HapMap-CEU project none of the SNPs tested in the GWAS is in near perfect proxy (r2>/=0.8) to the Phe217Leu polymorphism. Therefore, the GWAS data do not provide any additional information concerning the functional APH1B Phe217Leu SNP.
###end p 32
###begin p 33
In conclusion, our results suggest that the gamma-secretase pathway is a candidate pathway for premature coronary atherosclerosis and warrant further studies on genetic variations in this pathway in various diseases with vascular complications.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin title 35
Subjects
###end title 35
###begin p 36
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 588 596 <span type="species:ncbi:9606">patients</span>
###xml 1060 1067 <span type="species:ncbi:9606">patient</span>
We selected consecutive Dutch premature coronary atherosclerosis patients (n = 780, age 43.3+/-5.3; 582 males, age 43.6+/-5.3 and 198 females, age 42.5+/-5.5) who qualified for inclusion after a myocardial infarction, surgical or percutaneous coronary revascularization, or a coronary angiogram with evidence of at least a 70% stenosis in a major epicardial artery (Atherosclerosis Outpatient Clinic of the Academic Medical Center of the University of Amsterdam). The study was approved by the Medical Ethical Committee of the Academic Medical Center (Amsterdam, The Netherlands) and all patients gave written informed consent. The control subjects (n = 1414, age 51.8+/-11.9; 938 males, age 53.7+/-10.9 and 476 females, age 48.2+/-12.9) were from the Sanquin Blood Bank. Volunteers were recruited at their blood donation session at one of the collection sites of the Sanquin Blood Bank covering the north west of the Netherlands. Therefore more than >95% of these donors lived in the Dutch postal code area 1000-4000. This area was chosen while the Amsterdam patient cohort geographically overlaps the region of the blood donor cohort serving as control donors.
###end p 36
###begin title 37
Biochemical analysis
###end title 37
###begin p 38
###xml 23 31 <span type="species:ncbi:9606">patients</span>
In the atherosclerosis patients, plasma cholesterol and triglycerides were determined with commercially available enzymatic methods (Boehringer Mannheim, FRG, No. 237574, and Sera-PAK, No. 6639, respectively). To determine high-density lipoprotein cholesterol, the polyethylene glycol 6000 precipitation method was used. Low-density lipoprotein cholesterol was calculated by the Friedewald formula.
###end p 38
###begin title 39
APH1B genotyping
###end title 39
###begin p 40
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 193 222 193 222 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCCTTCTAGGGTTACCATCTGA-3&#8242;</named-content>
###xml 236 263 236 263 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTCGGCTTTACACTGTCCCA-3&#8242;</named-content>
###xml 326 354 326 354 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATAAACCTGGCGTCAGCATTT-3&#8242;</named-content>
###xml 396 424 396 424 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCCATGAGCACCAGGATTATC-3&#8242;</named-content>
Following the isolation of genomic DNA, APH1B (MIM# 607630) Phe217Leu genotyping was performed via allele-specific PCR using primers specific for SNP rs1047552 (outer/general primers: forward: 5'-TGCCTTCTAGGGTTACCATCTGA-3' and reverse: 5'-AGTCGGCTTTACACTGTCCCA-3'. Inner/specific primers: forward specific for the "T-allele": 5'-AATAAACCTGGCGTCAGCATTT-3' and reverse specific for the "G-allele": 5'-GCCCATGAGCACCAGGATTATC-3').
###end p 40
###begin title 41
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Generation of Aph1abc-/- mouse embryonic fibroblast (MEF) lines
###end title 41
###begin p 42
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1a</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1c</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1b</italic>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Serneels1">[36]</xref>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pgk</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 270 280 270 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1abc<sup>+/&#8722;</sup></italic>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 419 429 419 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1abc<sup>&#8722;/&#8722;</sup></italic>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Herreman1">[37]</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 171 186 <span type="species:ncbi:10090">transgenic mice</span>
###xml 228 233 <span type="species:ncbi:10090">Mouse</span>
###xml 347 352 <span type="species:ncbi:10090">Mouse</span>
###xml 430 435 <span type="species:ncbi:10090">mouse</span>
Conditionally targeted (Aph1a and Aph1c) or classically targeted (Aph1b) mice were described before [36]. Animals carrying a null allele were obtained after breeding with transgenic mice expressing a Pgk driven Cre-recombinase. Mouse embryos were dissected at E8.5 from Aph1abc+/- crosses and genotype was determined by PCR analysis on yolk sacs. Mouse embryonic fibroblast (MEF) cultures were derived from dissociated Aph1abc-/- mouse embryos [37].
###end p 42
###begin title 43
Generation of stable cell lines
###end title 43
###begin p 44
###xml 236 273 236 273 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGGCGTCAGCATTGATAATCCTGGTGCTC-3&#8242;</named-content>
###xml 285 322 285 322 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGCACCAGGATTATCAATGCTGACGCCAGG-3&#8242;</named-content>
###xml 591 594 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 584 594 578 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aph1abc<sup>&#8722;/&#8722;</sup></italic>
###xml 113 118 <span type="species:ncbi:9606">human</span>
The Phe217 to Leu217 mutation was made using the QuikChange II site-directed mutagenesis kit (Stratagene), using human wild-type APH1B cloned into pcDNA3.1 Zeo+ (Invitrogen) as template. The primers used to introduce the mutation were: 5'-CCTGGCGTCAGCATTGATAATCCTGGTGCTC-3' (forward); 5'-GAGCACCAGGATTATCAATGCTGACGCCAGG-3' (reverse). Phe217 and Leu217 hAPH1B were recloned into pMSCVpuro* and cotransfected into HEK293 cells with helper plasmid pIK Ecopac for packaging into retroviruses. Retroviruses were harvested and snap frozen aliquots were stored at -80degreesC until use. MEF Aph1abc-/- cells were transduced with retrovirus for 24 hrs followed by puromycin selection in DMEM/F12 supplemented with 10% FCS until stable lines were obtained.
###end p 44
###begin title 45
Measurement of gamma-secretase activity towards different substrates
###end title 45
###begin p 46
Stably transfected MEFs were seeded and grown to confluency. Cells were rinsed twice with ice-cold PBS and lysed in 1% Triton, and postnuclear fractions were isolated by centrifugation at 10,000 g for 15 min at 4degreesC. Proteins were quantified using a standard Bradford assay (Pierce) and 10-15 microg protein/lane was loaded on Bis-Tris SDS-PAGE gels (Invitrogen) and transferred to nitrocellulose membranes for Western blot detection for the indicated proteins. Gamma-secretase activity towards each substrate was expressed as the level of substrate C-terminal fragment (the direct gamma-secretase substrate) relative to levels of full-length protein. For densitometric quantification, the films were scanned using an Image Scanner (Amersham Pharmacia) and analyzed using ImageMaster.
###end p 46
###begin title 47
Antibodies
###end title 47
###begin p 48
APP was detected with C-terminal pAb B63.1 and syndecan 3 with C-terminal mAb 2E9. An antibody against the N-cadherin C-terminus (clone 32, BD Bioscience) was purchased.
###end p 48
###begin title 49
Statistical analysis
###end title 49
###begin p 50
###xml 181 182 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 301 306 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 460 461 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 770 774 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003662-Gauderman1">[38]</xref>
Genotype frequencies were tested for the Hardy-Weinberg equilibrium. Differences between cases and controls were analysed by standard contingency table analysis using two-tailed chi2 test probabilities. Odds ratios (95% confidence intervals (CI)) were calculated as an index of the association of the APH1B genotypes with premature atherosclerosis. Continuous and categorical biochemical and clinical variables were determined with the Student's t-test and chi2-analysis, respectively. A p-value<0.05 was considered statistically significant (GraphPad Software Inc, San Diego, CA, USA). Though being conservative, Bonferonni correction was used to determine the significance of the biochemical and clinical variables. Power calculations were estimated using Quanto v1.2 [38].
###end p 50
###begin p 51
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APH1B</italic>
###xml 288 293 <span type="species:ncbi:9606">human</span>
We thank Dr. Bart de Strooper (Department of Molecular and Developmental Genetics, VIB, Leuven, Belgium) for helpful support, Dr. Kenji Shirotani and Dr. Christian Haass (Laboratory for Alzheimer's and Parkinson's Disease Research, Ludwig-Maximilians-University, Munich, Germany) for the human APH1B wild-type plasmid, Dr. Guido David (Department of Molecular & Developmental Genetics, VIB, Leuven, Belgium) for the anti-Syndecan3 antibody 2E9 and Dr. Bruce Jenks (Department of Cellular Animal Physiology, Radboud University Nijmegen, The Netherlands) for critical reading of the manuscript.
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
###end article-title 53
###begin article-title 54
###xml 79 84 <span type="species:ncbi:9606">women</span>
Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease.
###end article-title 54
###begin article-title 55
[Gene Polymorphism of 5, 10-methylenetetrahydrofolate reductase as a coronary risk factor].
###end article-title 55
###begin article-title 56
###xml 72 83 <span type="species:ncbi:10116">Wistar rats</span>
Search after neurobiological profile of individual-specific features of Wistar rats.
###end article-title 56
###begin article-title 57
The role of genetic and early environmental factors in determining apomorphine susceptibility.
###end article-title 57
###begin article-title 58
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Stress susceptibility as a determinant of endothelium-dependent vascular reactivity in rat mesenteric arteries.
###end article-title 58
###begin article-title 59
###xml 118 121 <span type="species:ncbi:10116">rat</span>
Stress susceptibility as a determinant of the response to adrenergic stimuli in mesenteric resistance arteries of the rat.
###end article-title 59
###begin article-title 60
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
###end article-title 60
###begin article-title 61
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders.
###end article-title 61
###begin article-title 62
Gamma-secretase: proteasome of the membrane?
###end article-title 62
###begin article-title 63
Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration.
###end article-title 63
###begin article-title 64
Apolipoprotein E genetic variation and Alzheimer's disease. a meta-analysis.
###end article-title 64
###begin article-title 65
The LDL receptor-related protein (LRP1/A2MR) and coronary atherosclerosis-novel genomic variants and functional consequences.
###end article-title 65
###begin article-title 66
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease.
###end article-title 66
###begin article-title 67
Interaction between the APOE epsilon4 allele and the APH-1b c+651T>G SNP in Alzheimer's disease.
###end article-title 67
###begin article-title 68
SNPs3D: candidate gene and SNP selection for association studies.
###end article-title 68
###begin article-title 69
Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling.
###end article-title 69
###begin article-title 70
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.
###end article-title 70
###begin article-title 71
Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease.
###end article-title 71
###begin article-title 72
###xml 120 125 <span type="species:ncbi:9606">human</span>
Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions.
###end article-title 72
###begin article-title 73
###xml 99 105 <span type="species:ncbi:9986">rabbit</span>
Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development.
###end article-title 73
###begin article-title 74
Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
###end article-title 74
###begin article-title 75
Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP.
###end article-title 75
###begin article-title 76
An overview of Notch3 function in vascular smooth muscle cells.
###end article-title 76
###begin article-title 77
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice.
###end article-title 77
###begin article-title 78
Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis.
###end article-title 78
###begin article-title 79
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor.
###end article-title 79
###begin article-title 80
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development.
###end article-title 80
###begin article-title 81
Multiple essential functions of neuregulin in development.
###end article-title 81
###begin article-title 82
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.
###end article-title 82
###begin article-title 83
Familial occurrence of coronary heart disease: effect of age at diagnosis.
###end article-title 83
###begin article-title 84
Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.
###end article-title 84
###begin article-title 85
A common variant on chromosome 9p21 affects the risk of myocardial infarction.
###end article-title 85
###begin article-title 86
Genomewide association analysis of coronary artery disease.
###end article-title 86
###begin article-title 87
A common allele on chromosome 9 associated with coronary heart disease.
###end article-title 87
###begin article-title 88
Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo.
###end article-title 88
###begin article-title 89
gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation.
###end article-title 89
###begin article-title 90
Sample size requirements for association studies of gene-gene interaction.
###end article-title 90
###begin p 91
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 91
###begin p 92
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was performed within the framework of project T5-209 of the Dutch Top Institute Pharma.
###end p 92

